Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Clarinex
Generic Name
Desloratadine
Active Ingredient
DesloratadineCategory
Histamine-1 Receptor Antagonist [EPC]
Variants
2
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Clarinex, you must consult a qualified healthcare professional.
Detailed information about Clarinex
Desloratadine is a long-acting, non-sedating second-generation antihistamine used to treat symptoms of allergic rhinitis and chronic idiopathic urticaria. It works by selectively blocking H1 receptors.
For adults and adolescents aged 12 years and older, the standard recommended dose of desloratadine is 5 mg taken once daily. This dosage applies to all primary indications, including seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria.
Clinical trials have demonstrated that increasing the dose beyond 5 mg does not typically result in increased efficacy but may increase the risk of side effects, such as somnolence (drowsiness). Therefore, patients should strictly adhere to the 5 mg once-daily limit unless otherwise directed by a physician.
Desloratadine is approved for use in pediatric patients, but the dosage is strictly age-dependent. Healthcare providers use the following guidelines:
The safety and efficacy of desloratadine in children under 6 months of age have not been established. Always use a calibrated measuring device (such as an oral syringe) for the liquid formulation to ensure the child receives the correct dose.
In patients with compromised kidney function, the body may take longer to clear desloratadine. For adults with either permanent or temporary renal impairment, a starting dose of 5 mg every other day is often recommended. This adjustment helps prevent the accumulation of the drug to potentially toxic levels.
Because desloratadine is extensively metabolized by the liver, patients with hepatic (liver) insufficiency require cautious dosing. Similar to renal impairment, a starting dose of 5 mg every other day is generally recommended for adults with liver disease.
While no specific dosage adjustment is universally required for the elderly based solely on age, healthcare providers should be mindful that older patients are more likely to have decreased renal or hepatic function. Dosing should be initiated at the lower end of the range, and kidney function should be monitored.
If you miss a dose of desloratadine, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not take two doses at once to make up for a missed one, as this increases the risk of side effects.
In the event of an overdose, patients may experience exaggerated side effects, most notably extreme drowsiness (somnolence), rapid heart rate (tachycardia), and headache.
Emergency Measures: If an overdose is suspected, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally symptomatic and supportive. Desloratadine is not removed by hemodialysis (a procedure to clean the blood), so supportive care is the primary intervention.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop the medication without medical guidance, especially if you are using it to manage a chronic condition like urticaria.
Desloratadine is generally well-tolerated, and most side effects are mild and transient. In clinical trials, the incidence of side effects was only slightly higher than that of a placebo. The most frequently reported common side effects in adults include:
Desloratadine is a highly effective antihistamine, but it is not suitable for everyone. Before starting this medication, it is vital to disclose your full medical history to your healthcare provider. While it is marketed as non-drowsy, individual responses vary. Some people may experience a degree of somnolence (sleepiness) that could impair their ability to perform complex tasks.
No FDA black box warnings for Desloratadine. This medication is generally considered safe for the broad population when used according to the prescribed or labeled instructions.
There are no drugs that are strictly 'contraindicated' (never to be used) with desloratadine in the same way that some drugs interact with MAO inhibitors. However, desloratadine should not be used in combination with loratadine, as desloratadine is the active metabolite of loratadine. Taking both simultaneously is essentially a double-dose of the same active compound, significantly increasing the risk of toxicity and side effects.
There are few absolute contraindications for desloratadine, but they are critical for patient safety:
These are conditions where the drug may be used, but only after a careful risk-benefit analysis by a healthcare professional:
Desloratadine was previously classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans. In animal studies using doses much higher than the human therapeutic dose, some instances of decreased pup survival and decreased body weight were noted.
Healthcare providers typically recommend using desloratadine during pregnancy only if the symptoms are severe and other, more extensively studied options (like cetirizine or loratadine) are not preferred. Use during the first trimester is generally approached with the most caution.
Desloratadine and its metabolite, 3-hydroxydesloratadine, are excreted into breast milk. The amount of drug the infant receives is estimated to be very low. However, because antihistamines can potentially decrease milk production (especially if combined with a decongestant) and because of the potential for the infant to experience irritability or drowsiness, the decision to breastfeed while taking desloratadine should be made in consultation with a pediatrician. In many cases, it is considered 'probably compatible' with breastfeeding, but monitoring the infant for symptoms is essential.
Desloratadine is a selective H1-receptor antagonist that exhibits a unique pharmacological profile. Unlike first-generation antihistamines, it has a very low affinity for the muscarinic, adrenergic, and serotonergic receptors, which accounts for its reduced side-effect profile (less dry eye, less urinary retention).
At the molecular level, desloratadine binds to the H1 receptor with high affinity. It is considered an inverse agonist, meaning it shifts the equilibrium of the H1 receptor from its active state to its inactive state. This effectively prevents the downstream signaling that leads to the 'allergic cascade.' Furthermore, desloratadine's slow dissociation rate from the receptor contributes to its long duration of action, allowing for 24-hour symptom relief with a single dose.
Common questions about Clarinex
Desloratadine is primarily used to treat the symptoms of seasonal and year-round allergies, such as sneezing, runny nose, and itchy eyes. It is also highly effective for treating chronic idiopathic urticaria, which involves long-term hives and itching of unknown cause. By blocking the H1 histamine receptors, it prevents the body's allergic response to triggers like pollen, dust, and pet dander. It is available for adults and children as young as six months old. Your doctor may prescribe it to provide 24-hour relief from these bothersome symptoms.
The most common side effects reported by patients taking desloratadine include a sore throat, dry mouth, and muscle aches. Some individuals may also experience a mild degree of tiredness or sleepiness, although this is much less common than with older antihistamines. In children, the most frequent side effects are often diarrhea, fever, and headache. Most of these symptoms are mild and tend to go away as your body adjusts to the medication. If side effects persist or become bothersome, you should consult your healthcare provider for advice.
It is generally recommended to use caution when consuming alcohol while taking desloratadine. While desloratadine is a non-sedating antihistamine and does not typically interact strongly with alcohol in clinical studies, individual reactions can vary. Alcohol can increase the risk of dizziness or fatigue, which may be exacerbated by the medication. For some people, the combination might lead to unexpected drowsiness, which could impair driving or other tasks. It is best to discuss your alcohol consumption habits with your doctor before starting any new medication.
Desloratadine is generally only used during pregnancy if the potential benefits to the mother outweigh the potential risks to the developing fetus. It was previously classified as Category C, meaning animal studies showed some risks but human data is limited. Many doctors prefer to use antihistamines with a longer track record in pregnancy, such as loratadine or cetirizine, if treatment is necessary. You should always inform your obstetrician if you are taking desloratadine or planning to become pregnant. They will help you weigh the risks and benefits based on the severity of your allergy symptoms.
Desloratadine typically begins to work within 1 to 3 hours after you take your dose. Most patients notice a significant reduction in their allergy symptoms, such as sneezing and itching, within this timeframe. Because it has a long half-life, the effects of a single dose last for a full 24 hours. It is designed for once-daily use to provide continuous relief throughout the day and night. If you do not feel any improvement after several days of consistent use, you should contact your healthcare provider to re-evaluate your treatment plan.
Yes, you can generally stop taking desloratadine suddenly without experiencing withdrawal symptoms. It is not a habit-forming medication and does not require a tapering process. However, if you are taking it to manage chronic hives or persistent allergies, your symptoms may return shortly after you stop the medication. If you are planning to have an allergy skin test, you must stop taking desloratadine at least 3 to 7 days beforehand. Always consult your doctor before stopping a prescribed medication to ensure it is the right timing for your condition.
If you miss a dose of desloratadine, you should take it as soon as you remember. If it is already close to the time for your next scheduled dose, you should skip the missed dose and simply take your next one at the regular time. You should never take two doses at once to make up for a missed one, as this can increase the risk of side effects like a rapid heartbeat or extreme drowsiness. Setting a daily alarm or using a pillbox can help you stay consistent with your medication schedule. If you frequently miss doses, talk to your pharmacist about strategies to help you remember.
Weight gain is not a commonly reported side effect of desloratadine in clinical trials. While some older, first-generation antihistamines have been linked to increased appetite and weight gain due to their effects on the brain's histamine and serotonin receptors, desloratadine's high selectivity for peripheral receptors makes this much less likely. Most patients do not experience any change in weight while taking this medication. If you notice unexpected weight changes while on desloratadine, it is likely due to other factors, and you should discuss it with your doctor. They can help determine if the medication or another underlying issue is the cause.
Desloratadine can interact with certain other medications, particularly those that affect liver enzymes like ketoconazole, erythromycin, and cimetidine. These drugs can increase the levels of desloratadine in your blood, potentially increasing side effects. You should also be cautious when taking it with other sedating medications or anticholinergic drugs. It is essential to provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are currently taking. This allows them to check for any potentially harmful interactions before you start desloratadine.
Yes, desloratadine is widely available as a generic medication. Generic versions are bioequivalent to the brand-name version (Clarinex), meaning they contain the same active ingredient and work in the same way. Generic desloratadine is typically much more affordable than the brand-name version and is available in tablet, orally disintegrating tablet, and oral solution forms. Most insurance plans cover the generic version of this medication. You can ask your pharmacist for the generic equivalent to help save on your prescription costs while receiving the same therapeutic benefit.
Other drugs with the same active ingredient (Desloratadine)
These side effects occur less frequently but are still documented in clinical literature:
Rarely, patients may experience more unusual reactions, including:
While extremely rare, serious adverse events can occur. You should stop taking desloratadine and seek emergency care if you experience:
> Warning: Stop taking Desloratadine and call your doctor immediately if you experience any signs of a severe allergic reaction or liver dysfunction.
Desloratadine has been studied for long-term use, particularly in patients with chronic idiopathic urticaria. Data suggests that the drug maintains its efficacy over several months without the development of tolerance (where the drug becomes less effective over time). There is no evidence that long-term use of desloratadine causes organ damage or cumulative toxicity in healthy individuals. However, long-term users should still have periodic check-ups with their healthcare provider to ensure the medication remains appropriate for their needs.
As of 2024, there are no FDA black box warnings for desloratadine. It is considered to have a high safety margin when used as directed. Unlike some older antihistamines (like terfenadine), desloratadine does not have a significant risk of causing dangerous 'torsades de pointes' heart rhythms at therapeutic doses.
Report any unusual symptoms or persistent side effects to your healthcare provider. Even mild side effects can be managed with professional guidance, such as adjusting the time of day the medication is taken.
For the vast majority of patients, routine laboratory monitoring is not required while taking desloratadine. However, in specific cases, a healthcare provider may order:
In clinical trials, desloratadine at the recommended 5 mg dose did not produce impairment of psychomotor performance. However, because individual sensitivity to antihistamines varies, patients should be cautious when driving or operating heavy machinery until they are certain the medication does not make them feel drowsy or dizzy. Combining desloratadine with alcohol or other CNS depressants can significantly increase the risk of impairment.
While desloratadine does not have the potent sedative-potentiating effects of first-generation antihistamines, it is still generally advised to limit alcohol consumption while taking this medication. Alcohol can worsen dizziness or fatigue, and in some individuals, the combination may lead to unexpected levels of drowsiness.
Desloratadine does not typically require a tapering schedule. It can usually be stopped abruptly without the risk of a withdrawal syndrome. However, if you are taking it for chronic hives, stopping the medication may result in a return of the itching and wheals. If you are undergoing allergy skin testing, you must stop taking desloratadine at least 48 to 72 hours (and sometimes up to a week) before the test, as antihistamines will suppress the skin's reaction to allergens, leading to false-negative results.
> Important: Discuss all your medical conditions, including any history of kidney or liver disease, with your healthcare provider before starting Desloratadine.
Most interactions with desloratadine occur through the inhibition of metabolic enzymes (CYP3A4 and CYP2D6). When these enzymes are blocked by another drug (like ketoconazole), the body cannot break down desloratadine as quickly, leading to higher levels in the blood. Conversely, enzyme inducers (like St. John's Wort) speed up the breakdown, reducing efficacy.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the best way to prevent adverse drug-drug interactions.
Patients should be aware of cross-sensitivity within the piperidine class of antihistamines. While desloratadine is highly specific, individuals who have had severe reactions to other second-generation antihistamines should approach desloratadine with caution. There is no known cross-sensitivity between desloratadine and first-generation antihistamines like diphenhydramine (Benadryl) or chlorpheniramine.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug allergies, before prescribing Desloratadine. Always wear a medical alert bracelet if you have a known severe allergy to any medication.
Desloratadine is approved for children as young as 6 months of age. It is one of the few antihistamines with safety data for such young infants. However, it is not approved for use in children under 6 months.
Clinical studies of desloratadine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects. However, in general, elderly patients are more likely to have decreased renal or hepatic function.
In patients with chronic kidney disease (CKD), the clearance of desloratadine is significantly reduced.
In patients with hepatic impairment (e.g., cirrhosis), the half-life of desloratadine can be significantly prolonged. The Child-Pugh score may be used by clinicians to determine the severity of liver disease. For most patients with liver impairment, the 'every other day' dosing rule applies to prevent the drug from reaching toxic concentrations in the blood.
> Important: Special populations require individualized medical assessment. Never share your medication with others, especially those in these sensitive categories.
| Parameter | Value |
|---|---|
| Bioavailability | Not precisely quantified in humans; unaffected by food |
| Protein Binding | 82% to 87% (Desloratadine); 85% to 89% (3-OH metabolite) |
| Half-life | ~27 hours |
| Tmax | ~3 hours |
| Metabolism | Hepatic (Hydroxylation to 3-hydroxydesloratadine) |
| Excretion | Renal 41%, Fecal 47% |
Desloratadine is classified as a Second-Generation Antihistamine and a H1-Receptor Antagonist [EPC]. It is therapeutically related to other non-sedating antihistamines such as loratadine, cetirizine, and fexofenadine. Among these, desloratadine is often noted for having the longest half-life and the highest receptor affinity.